Therapeutic drug monitoring of mycophenolic acid: comparison of HPLC and immunoassay reveals new MPA metabolites.
Schütz
E
E
Abteilung für Klinische Chemie, Georg-August Universität, Goettingen, Germany.
Shipkova
M
M
Armstrong
V W
VW
Niedmann
P D
PD
Weber
L
L
Tönshoff
B
B
Pethig
K
K
Wahlers
T
T
Braun
F
F
Ringe
B
B
Oellerich
M
M
D000328:Adult; D002648:Child; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D016572:Cyclosporine / Q000627:therapeutic use; D016903:Drug Monitoring; D004359:Drug Therapy, Combination; D017248:Enzyme Multiplied Immunoassay Technique; D016027:Heart Transplantation / Q000276:immunology* / Q000502:physiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D016031:Liver Transplantation / Q000276:immunology* / Q000502:physiology; D008657:Metabolic Clearance Rate; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D009173:Mycophenolic Acid